In reply
Ross' remarks to our article1 give us the welcome opportunity to explain our position in more detail. Our point is that there are not enough best-interest arguments to deny genetic testing to an adolescent at risk of carrying a BRCA1 mutation. Therefore, guidelines should differentiate between children and adolescents. The question is, "Are there compelling justifications, ethical or practical, to wait until the adolescent reaches the age of majority?"2